Alzheimer’s Disease

A practical approach to cognitive impairment management

Important developments in dementia: biomarkers & clinical trials

Targeting β-amyloid and tau in Alzheimer’s disease

Understanding Alzheimer’s disease in Down’s syndrome

The validity of the amyloid cascade hypothesis of Alzheimer’s disease

Should findings from monogenic dementias inform sporadic disease research?

Including people with Down’s syndrome in Alzheimer’s disease research

The current state of gene editing in treating Alzheimer’s disease

The role of β-amyloid in AD: still a central characteristic?

Limitations in understanding Alzheimer’s disease for gene editing

Are viruses a major cause of amyloid deposition in Alzheimer’s disease?

Implications of heterogeneity in Alzheimer’s disease

Opportunities and challenges of biomarkers in Alzheimer’s disease

Unanswered questions in Alzheimer’s disease research

Early diagnosis & genetic risk in Alzheimer’s disease

What happens to the blood-brain barrier in neurodegenerative disease?